Mednow Inc. Acquires Infusicare Canada Inc.

December 13, 2021

Mednow Inc. (TSXV:MNOW) has completed the acquisition of Infusicare Canada Inc. for C$1.85 million in cash. The specialty pharmacy, which generated C$9.3 million in revenue in its last fiscal year, will be integrated into Mednow’s digital pharmacy platform to expand its specialty and biologic drug offerings.

Buyers
Mednow Inc.
Targets
Infusicare Canada Inc.
Sellers
Amir Ali Reyany-Bozorg, Felipe Campusano
Location
Canada
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.